nodes	percent_of_prediction	percent_of_DWPC	metapath
Progabide—GABBR1—GPCRs, Class C Metabotropic glutamate, pheromone—GRM8—lung cancer	0.115	0.117	CbGpPWpGaD
Progabide—GABBR1—Class C/3 (Metabotropic glutamate/pheromone receptors)—GRM8—lung cancer	0.0525	0.0532	CbGpPWpGaD
Progabide—GABBR1—Activation of GABAB receptors—ADCY1—lung cancer	0.0379	0.0384	CbGpPWpGaD
Progabide—GABBR1—GABA receptor activation—ADCY1—lung cancer	0.029	0.0294	CbGpPWpGaD
Progabide—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK3—lung cancer	0.0254	0.0258	CbGpPWpGaD
Progabide—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—lung cancer	0.0207	0.021	CbGpPWpGaD
Progabide—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—lung cancer	0.0193	0.0195	CbGpPWpGaD
Progabide—GABBR1—Transmission across Chemical Synapses—GRIK3—lung cancer	0.0191	0.0194	CbGpPWpGaD
Progabide—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—lung cancer	0.0157	0.0159	CbGpPWpGaD
Progabide—GABBR1—Transmission across Chemical Synapses—CHRNB4—lung cancer	0.0156	0.0158	CbGpPWpGaD
Progabide—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG11—lung cancer	0.0149	0.015	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—GRIK3—lung cancer	0.0146	0.0148	CbGpPWpGaD
Progabide—GABBR1—Transmission across Chemical Synapses—CHRNA5—lung cancer	0.0145	0.0147	CbGpPWpGaD
Progabide—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY1—lung cancer	0.0134	0.0135	CbGpPWpGaD
Progabide—Bezafibrate—CYP1A1—lung cancer	0.0131	1	CrCbGaD
Progabide—GABBR1—G alpha (i) signalling events—GRM8—lung cancer	0.0127	0.0129	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—CHRNB4—lung cancer	0.0119	0.0121	CbGpPWpGaD
Progabide—GABBR1—Transmission across Chemical Synapses—CHRNA3—lung cancer	0.0118	0.012	CbGpPWpGaD
Progabide—GABBR1—Transmission across Chemical Synapses—GNG11—lung cancer	0.0112	0.0113	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—CHRNA5—lung cancer	0.0111	0.0112	CbGpPWpGaD
Progabide—GABRA1—GABA receptor activation—ADCY1—lung cancer	0.0101	0.0102	CbGpPWpGaD
Progabide—GABBR1—Transmission across Chemical Synapses—ADCY1—lung cancer	0.01	0.0102	CbGpPWpGaD
Progabide—GABBR1—G alpha (i) signalling events—GNG11—lung cancer	0.00981	0.00994	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—GIPR—lung cancer	0.00906	0.00918	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—CHRNA3—lung cancer	0.00905	0.00917	CbGpPWpGaD
Progabide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK3—lung cancer	0.00885	0.00896	CbGpPWpGaD
Progabide—GABBR1—G alpha (i) signalling events—ADCY1—lung cancer	0.00882	0.00894	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—GNG11—lung cancer	0.00855	0.00867	CbGpPWpGaD
Progabide—GABBR1—G alpha (i) signalling events—ANXA1—lung cancer	0.00771	0.00781	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—GRM8—lung cancer	0.00771	0.00781	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—ADCY1—lung cancer	0.00769	0.00779	CbGpPWpGaD
Progabide—GABBR1—G alpha (i) signalling events—APP—lung cancer	0.00731	0.00741	CbGpPWpGaD
Progabide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—lung cancer	0.00721	0.00731	CbGpPWpGaD
Progabide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—lung cancer	0.0067	0.00679	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—GRIK3—lung cancer	0.00665	0.00674	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—CHRNB4—lung cancer	0.00661	0.0067	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—GRP—lung cancer	0.00635	0.00643	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—OXTR—lung cancer	0.00635	0.00643	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—GNG11—lung cancer	0.00594	0.00602	CbGpPWpGaD
Progabide—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.00565	0.00572	CbGpPWpGaD
Progabide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—lung cancer	0.00546	0.00554	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—CHRNB4—lung cancer	0.00542	0.00549	CbGpPWpGaD
Progabide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG11—lung cancer	0.00517	0.00524	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—GIPR—lung cancer	0.00512	0.00519	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—GRIK3—lung cancer	0.0051	0.00516	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—CHRNA5—lung cancer	0.00504	0.00511	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—FOXM1—lung cancer	0.00501	0.00508	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—PTHLH—lung cancer	0.00497	0.00503	CbGpPWpGaD
Progabide—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.00473	0.00479	CbGpPWpGaD
Progabide—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.00471	0.00478	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—ANXA1—lung cancer	0.00467	0.00473	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—SOX2—lung cancer	0.00466	0.00472	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—GIPR—lung cancer	0.00465	0.00471	CbGpPWpGaD
Progabide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY1—lung cancer	0.00465	0.00471	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—ALDOA—lung cancer	0.00451	0.00457	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—APP—lung cancer	0.00443	0.00449	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—GRM8—lung cancer	0.00436	0.00441	CbGpPWpGaD
Progabide—GABBR1—Transmission across Chemical Synapses—BRAF—lung cancer	0.00424	0.0043	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—CHRNB4—lung cancer	0.00415	0.00421	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—CHRNA3—lung cancer	0.00411	0.00416	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—TF—lung cancer	0.00396	0.00401	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—GRM8—lung cancer	0.00396	0.00401	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.00389	0.00394	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—GNG11—lung cancer	0.00388	0.00394	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—CHRNA5—lung cancer	0.00386	0.00391	CbGpPWpGaD
Progabide—GABBR1—G alpha (i) signalling events—POMC—lung cancer	0.00378	0.00383	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—AXL—lung cancer	0.00363	0.00367	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—GRP—lung cancer	0.00359	0.00363	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—OXTR—lung cancer	0.00359	0.00363	CbGpPWpGaD
Progabide—GABBR1—Transmission across Chemical Synapses—MDM2—lung cancer	0.00356	0.0036	CbGpPWpGaD
Progabide—GABBR1—Transmission across Chemical Synapses—RAF1—lung cancer	0.00354	0.00359	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—ADCY1—lung cancer	0.00349	0.00354	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—AVP—lung cancer	0.00344	0.00349	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—GNG11—lung cancer	0.00336	0.0034	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—GRP—lung cancer	0.00326	0.0033	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—OXTR—lung cancer	0.00326	0.0033	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—BRAF—lung cancer	0.00325	0.0033	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—CHRNA3—lung cancer	0.00315	0.00319	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—GNG11—lung cancer	0.00305	0.00309	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—ADCY1—lung cancer	0.00302	0.00306	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—GNG11—lung cancer	0.00298	0.00302	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.00295	0.00299	CbGpPWpGaD
Progabide—GABBR1—G alpha (i) signalling events—CXCL8—lung cancer	0.00292	0.00296	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—COL4A2—lung cancer	0.00282	0.00286	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—PTHLH—lung cancer	0.00281	0.00284	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—GIPR—lung cancer	0.00275	0.00278	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—AVP—lung cancer	0.00275	0.00278	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—ADCY1—lung cancer	0.00274	0.00278	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—MDM2—lung cancer	0.00273	0.00276	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—RAF1—lung cancer	0.00272	0.00275	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—ADCY1—lung cancer	0.00268	0.00271	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—PPP2R1B—lung cancer	0.00267	0.00271	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—ANXA1—lung cancer	0.00264	0.00267	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—HES1—lung cancer	0.0026	0.00263	CbGpPWpGaD
Progabide—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.0026	0.00263	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—IL10—lung cancer	0.00258	0.00262	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—SDC4—lung cancer	0.00257	0.0026	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—PTHLH—lung cancer	0.00255	0.00258	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—DUSP3—lung cancer	0.00251	0.00255	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—APP—lung cancer	0.0025	0.00253	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—RHEB—lung cancer	0.00246	0.0025	CbGpPWpGaD
Progabide—GABRA1—Orphan transporters—CREBBP—lung cancer	0.00246	0.00249	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—ANXA1—lung cancer	0.0024	0.00243	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—GRM8—lung cancer	0.00234	0.00237	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—POMC—lung cancer	0.00229	0.00232	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—APP—lung cancer	0.00227	0.0023	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—SKI—lung cancer	0.00226	0.00229	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.00218	0.0022	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PXN—lung cancer	0.00197	0.00199	CbGpPWpGaD
Progabide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.00196	0.00199	CbGpPWpGaD
Progabide—GABBR1—Transmission across Chemical Synapses—HRAS—lung cancer	0.00195	0.00198	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—AVP—lung cancer	0.00195	0.00197	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—AKR1C1—lung cancer	0.00192	0.00195	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—OXTR—lung cancer	0.00192	0.00195	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—GRP—lung cancer	0.00192	0.00195	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—GNG11—lung cancer	0.0018	0.00183	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—IL6R—lung cancer	0.00178	0.0018	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.00178	0.0018	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—CXCL8—lung cancer	0.00177	0.00179	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—AVP—lung cancer	0.00177	0.00179	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—ABCC3—lung cancer	0.00177	0.00179	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—VEGFC—lung cancer	0.00171	0.00174	CbGpPWpGaD
Progabide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.00165	0.00167	CbGpPWpGaD
Progabide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.00164	0.00166	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—ADCY1—lung cancer	0.00162	0.00164	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—GNG11—lung cancer	0.0016	0.00162	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—SMARCA4—lung cancer	0.00158	0.0016	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PPP2R1B—lung cancer	0.00158	0.0016	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—HSPB1—lung cancer	0.00152	0.00154	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PTHLH—lung cancer	0.00151	0.00153	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—HRAS—lung cancer	0.0015	0.00152	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—BRAF—lung cancer	0.00148	0.0015	CbGpPWpGaD
Progabide—GABRA1—Ion channel transport—RAF1—lung cancer	0.00146	0.00148	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—ADCY1—lung cancer	0.00144	0.00146	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—ABCG2—lung cancer	0.00144	0.00146	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—ANXA1—lung cancer	0.00142	0.00143	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.00141	0.00143	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—FLT1—lung cancer	0.00137	0.00139	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—PIK3CG—lung cancer	0.00136	0.00138	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—CASP3—lung cancer	0.00135	0.00137	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—NOTCH3—lung cancer	0.00134	0.00136	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—APP—lung cancer	0.00134	0.00136	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—TF—lung cancer	0.00134	0.00136	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—FGF9—lung cancer	0.00133	0.00135	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—JUN—lung cancer	0.00131	0.00133	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—POMC—lung cancer	0.00129	0.00131	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—JUNB—lung cancer	0.00127	0.00129	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—MDM2—lung cancer	0.00124	0.00125	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—PIK3CG—lung cancer	0.00123	0.00125	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—RAF1—lung cancer	0.00123	0.00125	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—EP300—lung cancer	0.00121	0.00123	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—PIK3CD—lung cancer	0.00119	0.00121	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—POMC—lung cancer	0.00117	0.00119	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—STK11—lung cancer	0.00115	0.00117	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.00115	0.00116	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—IL6R—lung cancer	0.00115	0.00116	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—BRAF—lung cancer	0.00113	0.00115	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—FOXO3—lung cancer	0.00111	0.00113	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—MAP2K1—lung cancer	0.00109	0.00111	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—PIK3CD—lung cancer	0.00108	0.0011	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—AVP—lung cancer	0.00104	0.00106	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—PIK3CB—lung cancer	0.00104	0.00105	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—IGF1R—lung cancer	0.001	0.00102	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—CXCL8—lung cancer	0.001	0.00101	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—HES1—lung cancer	0.000987	0.001	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—RAF1—lung cancer	0.000968	0.000981	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—IL2—lung cancer	0.000956	0.000968	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—MDM2—lung cancer	0.000948	0.000961	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—PIK3CB—lung cancer	0.000945	0.000958	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—RAF1—lung cancer	0.000945	0.000958	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—AVP—lung cancer	0.000927	0.00094	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—CXCL8—lung cancer	0.000908	0.00092	CbGpPWpGaD
Progabide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000903	0.000915	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—ERBB3—lung cancer	0.000902	0.000914	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000898	0.00091	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—IL2—lung cancer	0.000868	0.000879	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—TERT—lung cancer	0.000865	0.000876	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—FGFR1—lung cancer	0.00084	0.000851	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—HIF1A—lung cancer	0.000827	0.000838	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—APOA1—lung cancer	0.000798	0.000809	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—IL6—lung cancer	0.000793	0.000803	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—KDR—lung cancer	0.000791	0.000801	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—APC—lung cancer	0.000729	0.000738	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—KIT—lung cancer	0.000729	0.000738	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PIK3CG—lung cancer	0.000729	0.000738	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—NRAS—lung cancer	0.000729	0.000738	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—EGF—lung cancer	0.00072	0.00073	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—APOA1—lung cancer	0.000709	0.000718	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—MAPK3—lung cancer	0.000698	0.000707	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—POMC—lung cancer	0.000694	0.000703	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—BRAF—lung cancer	0.000685	0.000694	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—HRAS—lung cancer	0.000679	0.000688	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—IL6R—lung cancer	0.000677	0.000686	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—CREBBP—lung cancer	0.000676	0.000684	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—EGFR—lung cancer	0.000664	0.000673	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—MAP2K1—lung cancer	0.000645	0.000653	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PIK3CD—lung cancer	0.000641	0.000649	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—PIK3CA—lung cancer	0.000634	0.000643	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—KRAS—lung cancer	0.000627	0.000635	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—CREBBP—lung cancer	0.0006	0.000608	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—PIK3CA—lung cancer	0.000576	0.000584	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—MDM2—lung cancer	0.000574	0.000581	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—RAF1—lung cancer	0.000572	0.000579	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—ERBB2—lung cancer	0.000566	0.000573	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—ALB—lung cancer	0.000562	0.000569	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—MTOR—lung cancer	0.000558	0.000566	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PIK3CB—lung cancer	0.000558	0.000566	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—CXCL8—lung cancer	0.000537	0.000544	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—HRAS—lung cancer	0.000533	0.00054	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—HRAS—lung cancer	0.00052	0.000527	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—AKT1—lung cancer	0.000518	0.000525	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—CASP3—lung cancer	0.000514	0.00052	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—IL2—lung cancer	0.000513	0.00052	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—IL6—lung cancer	0.00051	0.000517	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—RAF1—lung cancer	0.000508	0.000515	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—CCND1—lung cancer	0.0005	0.000506	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—JUN—lung cancer	0.000499	0.000505	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—MMP9—lung cancer	0.000485	0.000492	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—CDKN1A—lung cancer	0.000484	0.00049	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PTEN—lung cancer	0.000482	0.000489	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—AKT1—lung cancer	0.000471	0.000477	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—EP300—lung cancer	0.00046	0.000466	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—SRC—lung cancer	0.000447	0.000453	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—VEGFA—lung cancer	0.000436	0.000442	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—STAT3—lung cancer	0.000431	0.000437	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—NRAS—lung cancer	0.00043	0.000436	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—MAPK3—lung cancer	0.000412	0.000418	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—MYC—lung cancer	0.000401	0.000406	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—EGFR—lung cancer	0.000392	0.000397	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—KRAS—lung cancer	0.00037	0.000375	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PIK3CA—lung cancer	0.00034	0.000345	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—TP53—lung cancer	0.000329	0.000334	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—HRAS—lung cancer	0.000315	0.000319	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—IL6—lung cancer	0.000301	0.000305	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—AKT1—lung cancer	0.000278	0.000282	CbGpPWpGaD
